Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 40:
41. The compound of claim 37, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2 is 5-membered heterocyclyl, wherein the 5-membered heterocyclyl is substituted by 1, 2, 3, 4, or 5 independently selected R2c substituents:
at least one R2c is 5- to 10-membered heteroaryl, wherein the 5- to 10-membered heteroaryl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R4a substituents; and
each R4a is an independently selected 0-5 C1-C6 alkyl substituent.